Bristol Myers’ RayzeBio halts radiotherapy trial enrollment after isotope runs scarce fkansteiner Mon, 06/03/2024 – 15:01 More: Bristol Myers' RayzeBio halts radiotherapy trial enrollment after isotope runs scarce Source: fierce
read moreASCO: With first-in-class win, Sanofi’s Sarclisa looks to step out of J&J’s multiple myeloma shadow aliu Mon, 06/03/2024 – 14:23 More: ASCO: With first-in-class win, Sanofi's Sarclisa looks to step out of J&J's multiple myeloma shadow Source: fierce
read moreIllumina recruits Pfizer, Exact Sciences alum as new commercial chief apark Mon, 06/03/2024 – 13:16 More: Illumina recruits Pfizer, Exact Sciences alum as new commercial chief Source: fierce
read moreLotte Biologics, Merck KGaA ink partnership deal for biopharma production jkeenan Mon, 06/03/2024 – 11:37 More: Lotte Biologics, Merck KGaA ink partnership deal for biopharma production Source: fierce
read moreAhead of bankruptcy sale, Acorda fights on with new Inbrija TV spot apark Mon, 06/03/2024 – 11:24 More: Ahead of bankruptcy sale, Acorda fights on with new Inbrija TV spot Source: fierce
read more
Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy More: New UCL-developed immunotherapy shows promising results in treating bone cancer Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals